British scientists have confirmed that the cannabis compound Tetrahydrocannabinol (THC) can be used as a therapy against tumor growth. The plant has been found to slow down the growth of cancerous tumors, providing an alternative to the aggressive treatments such as chemotherapy. Medical studies have shown that cannabis has a positive effect on cancer treatment, and the University of East Anglia has conducted in-depth research on the molecular level to explain the effects of THC. The results show the interaction between the receptors and the chemical substance, providing insight into the effectiveness of cannabis against malignant tumors.
Dr. Peter McCormick, who led the research, described the findings as a significant breakthrough. However, he emphasized the importance of medical supervision and the concentration of the chemical substance in the medication. Self-medication is strongly discouraged. Despite the positive healing effects of cannabis, the pharmaceutical industry has shown little interest in producing the substance on a large scale. This is due to the fact that the natural raw material cannot be patented, making it less profitable for the industry to produce a marketable drug.
Dr. McCormick remains committed to synthesizing cannabis effectively and making it available to patients in need. The acceptance of cannabis as a therapeutic drug remains a challenge, but the research provides a promising step towards a more natural and less invasive treatment for cancer patients. The potential of cannabis as a pain reliever and a cancer treatment is well-known, and the confirmation of its effectiveness by scientific research is a significant development in the field of medicine.
